Uterine leiomyosarcoma arising in leiomyoma: Clinicopathological study of four cases and literature review

被引:36
作者
Yanai, Hiroyuki [1 ]
Wani, Yoji [2 ]
Notohara, Kenji [2 ]
Takada, Shin-ichi [4 ]
Yoshino, Tadashi [3 ]
机构
[1] Okayama Univ Hosp, Dept Pathol, Okayama 7008558, Japan
[2] Kurashiki Cent Hosp, Dept Pathol, Okayama, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan
[4] Hiroshima City Hosp, Dept Pathol, Hiroshima, Japan
关键词
Ki-67; leiomyoma; leiomyosarcoma; p16; p53; SMOOTH-MUSCLE TUMORS; BROAD LIGAMENT; KI-67; EXPRESSION; P53; UTERUS; P16; ESTROGEN; IMMUNOREACTIVITY; CLASSIFICATION; RECEPTORS;
D O I
10.1111/j.1440-1827.2010.02549.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In this study we examined four cases of leiomyosarcoma (LMS) arising in leiomyoma (LM). The patients ranged from 40 to 64 years old. Symptoms were unspecific and preoperative diagnosis of LMS had not been made. Size of the tumors ranged from 4 cm to 20.5 cm. All patients were in stage I and no patients developed recurrent disease. Histologically, the LMS component showed moderate to severe cytological atypia and an increased mitotic count in all cases. Tumor cell necrosis in the LMS was seen in three cases. Associated LM component was cellular in one case. The LMS component showed p53 expression in three of four cases and p16 expression was seen in two cases. The LM component lacked p53 expression in all cases and demonstrated p16 expression in two cases, including one case of cellular LM. In all cases, Ki-67-positive cells were less than 5% in the LM component and more than 25-30% in the LMS component. This study reveals that: (i) malignant transformation can occur even in relatively small LM; (ii) patients with LMS with an LM component have a favorable prognosis; and (iii) immunohistochemical examination of p53, p16 and Ki-67 is useful for identification of malignant focus.
引用
收藏
页码:506 / 509
页数:4
相关论文
共 34 条
  • [1] The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas: A clinicopathologic study
    Akhan, SE
    Yavuz, E
    Tecer, A
    Iyibozkurt, CA
    Topuz, S
    Tuzlali, S
    Bengisu, E
    Berkman, S
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (01) : 36 - 42
  • [2] LEIOMYOSARCOMA VERSUS BIZARRE AND CELLULAR LEIOMYOMAS OF THE UTERUS - A COMPARATIVE-STUDY BASED ON THE MIB-1 AND PROLIFERATING CELL NUCLEAR ANTIGEN INDEXES, P53 EXPRESSION, DNA FLOW-CYTOMETRY, AND MUSCLE-SPECIFIC ACTINS
    AMADA, S
    NAKANO, H
    TSUNEYOSHI, M
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1995, 14 (02) : 134 - 142
  • [3] The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors
    Atkins, Kristen A.
    Arronte, Nora
    Darus, Christopher J.
    Rice, Laurel W.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (01) : 98 - 102
  • [4] Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases
    Blom, R
    Guerrieri, C
    Stal, O
    Malmstrom, H
    Simonsen, E
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 68 (01) : 54 - 61
  • [5] Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis
    Bodner-Adler, B
    Bodner, K
    Czerwenka, K
    Kimberger, O
    Leodolter, S
    Mayerhofer, K
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 62 - 66
  • [6] Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors
    Chen, Longwen
    Yang, Bin
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (03) : 326 - 332
  • [7] Differential immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants
    Gannon, Brian R.
    Manduch, Marosh
    Childs, Timothy J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (01) : 68 - 73
  • [8] Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors
    Gökasalan, H
    Türkeri, L
    Kavak, ZN
    Eren, F
    Sismanoglu, A
    Ilvan, S
    Durmusoglu, F
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2005, 59 (01) : 36 - 40
  • [9] HART WR, 1978, CANCER-AM CANCER SOC, V41, P1902, DOI 10.1002/1097-0142(197805)41:5<1902::AID-CNCR2820410535>3.0.CO
  • [10] 2-K